Explore 4-Bromo-3,5-dimethoxyamphetamine

PiHKAL book II entry 4-Br-3,5-DMA

ChemSpider 180279
PubChem 208044
Wikidata Q4637107
Wikipedia 4-Bromo-3,5-dimethoxyamphetamine
Rhodium First synthesis of DOB

Shulgin Index See #52 DOB · Table 5Page 349Row 11

Phenethylamine: Von der Strucktur zur Funktion 4-Br-3,5-DMA: 8.4 (155) 740, 741

Barfknecht, CF; Nichols, DE. Potential psychotomimetics. Bromomethoxyamphetamines. J. Med. Chem., 1 Apr 1971, 14 (4), 370–372. 377 kB. https://doi.org/10.1021/jm00286a026 #5 Rhodium

Antun, F; Smythies, JR; Benington, F; Morin, RD; Barfknecht, CF; Nichols, DE. Native fluorescence and hallucinogenic potency of some amphetamines. Experientia, 15 Jan 1971, 27 (1), 62–63. 248 kB. https://doi.org/10.1007/BF02137743 other

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; pp 243–333. 2.6 MB. https://doi.org/10.1007/978-1-4757-0510-2_6 #85 Rhodium.

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. https://doi.org/10.1016/j.bmc.2003.10.027 #6

Brimblecombe, RW; Pinder, RM. Hallucinogenic agents, Wright-Scientechnica, Bristol, UK, 1 Jan 1975. 46.2 MB. #3.41

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.

Braun, U; Braun, G; Jacob, P; Nichols, DE; Shulgin, AT. Mescaline Analogs: Substitutions at the 4-Position. In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1978; pp 27–37. 497 kB. Rhodium.

Nichols, DE. Potential psychotomimetics: Bromomethoxyamphetamines and structural congeners of lysergic acid. Ph. D. Thesis, University of Iowa, Iowa City, IA, 1 May 1973. 13.0 MB. #43e NMR,IR,other

Dowd, CS; Herrick-Davis, K; Egan, C; DuPre, A; Smith, C; Teitler, M; Glennon, RA. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT_2A partial agonists. J. Med. Chem., 10 Aug 2000, 43 (16), 3074–3084. 271 kB. https://doi.org/10.1021/jm9906062 #25 NMR,IR

Nichols, DE; Shulgin, AT; Dyer, DC. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives. Life Sci., 15 Aug 1977, 21 (4), 569–576. 320 kB. https://doi.org/10.1016/0024-3205(77)90099-6 #27

Clare, BW. The frontier orbital phase angles: Novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens. J. Med. Chem., 24 Sep 1998, 41 (20), 3845–3856. 239 kB. https://doi.org/10.1021/jm980144c #59

4-Bromo-2,5-dimethoxyamphetamine · DOB

5-Br-2,4-DMA · 5-Bromo-2,4-dimethoxyamphetamine · m-DOB · META-DOB

2C-B-2-EtO · 2CB-2ETO · 4-Bromo-2-ethoxy-5-methoxyphenethylamine

2-Bromo-4,5-dimethoxy-N-methylphenethylamine · N-Me-2-Br-DMPEA

2-Br-4,5-DMA · 2-Bromo-4,5-dimethoxyamphetamine · o-DOB · ORTHO-DOB

5,2,3-DOB · 5-Br-2,3-DMA

6,2,3-DOB · 6-Br-2,3-DMA

3,2,6-DOB · 3-Br-2,6-DMA

2,3,5-DOB · 2-Br-3,5-DMA

4,2,6-DOB · ψ-DOB

2C-B-M · N-Me-2C-B

4,2,3-DOB · 4-Bromo-2,3-dimethoxyamphetamine

3,2,4-DOB · 3-Bromo-2,4-dimethoxyamphetamine

2,3,4-DOB · 2-Bromo-3,4-dimethoxyamphetamine

3-Bromo-2,5-dimethoxyamphetamine · 3-DOB · iso-DOB

2C-B-5-EtO · 4-Bromo-5-ethoxy-2-methoxyphenethylamine

3,4,5-DOB · 3-Bromo-4,5-dimethoxyamphetamine

2,3,6-DOB · 2-Bromo-3,6-dimethoxyamphetamine

2,4,6-DOB · 2-Bromo-4,6-dimethoxyamphetamine

4-Bromo-2,5-dimethoxy-β-methylphenethylamine · BMB

3-Br-2C-D · 3-Bromo-4-methyl-2,5-dimethoxyphenethylamine

p1-197: 4-Br-3,5-DMA